Figure 1.
Relationship between clinical HIT and antibody formation. Only a minority of patients with heparin-PF4 antibodies shown by ELISA demonstrate functional antibodies by SRA, and only a fraction of these will develop clinical disease (HIT or HIT-T). The true frequency of antibody formation and an accurate estimate of risk for clinical disease in the pediatric population are not well known.